These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29273101)

  • 1. Treatment of Alopecia Areata with Simvastatin/Ezetimibe.
    Cervantes J; Jimenez JJ; DelCanto GM; Tosti A
    J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S25-S31. PubMed ID: 29273101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hair growth in patients alopecia areata totalis after treatment with simvastatin and ezetimibe.
    Ali A; Martin JM
    J Drugs Dermatol; 2010 Jan; 9(1):62-4. PubMed ID: 20120427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alopecia Universalis after Treatment with Simvastatin and Ezetimibe: Affects on Family.
    Ozyurtlu F; Cetin N
    Arq Bras Cardiol; 2022 Oct; 119(4):631-633. PubMed ID: 36287418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
    Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
    J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T-cells in alopecia areata.
    Speiser JJ; Mondo D; Mehta V; Marcial SA; Kini A; Hutchens KA
    J Cutan Pathol; 2019 Sep; 46(9):653-658. PubMed ID: 30989699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective outcome analysis of 25 alopecia areata patients treated with simvastatin/ezetimibe.
    Morillo-Hernandez C; Lee JJ; English JC
    J Am Acad Dermatol; 2019 Sep; 81(3):854-857. PubMed ID: 31015012
    [No Abstract]   [Full Text] [Related]  

  • 7. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
    Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
    Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia areata: a review of disease pathogenesis.
    Rajabi F; Drake LA; Senna MM; Rezaei N
    Br J Dermatol; 2018 Nov; 179(5):1033-1048. PubMed ID: 29791718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata.
    Ito T; Tokura Y
    Exp Dermatol; 2014 Nov; 23(11):787-91. PubMed ID: 25040075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cells.
    Singh V; Mueller U; Freyschmidt-Paul P; Zöller M
    Eur J Immunol; 2011 Oct; 41(10):2871-82. PubMed ID: 21728175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia Areata: A Complex Cytokine Driven Disease.
    Song T; Guttman-Yassky E
    J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S55-S57. PubMed ID: 33099386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata.
    Happle R; Klein HM; Macher E
    Arch Dermatol Res; 1986; 278(3):214-8. PubMed ID: 2873796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia areata: autoimmune basis of hair loss.
    Alexis AF; Dudda-Subramanya R; Sinha AA
    Eur J Dermatol; 2004; 14(6):364-70. PubMed ID: 15564197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.
    Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS
    J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
    Gao Z; Jin YQ; Wu W
    Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.
    Zöller M; McElwee KJ; Vitacolonna M; Hoffmann R
    J Autoimmun; 2004 Nov; 23(3):241-56. PubMed ID: 15501395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata: autoimmunity--the evidence is compelling.
    Kalish RS; Gilhar A
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
    Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
    Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recalcitrant alopecia areata responsive to leflunomide and anthralin-Potentially undiscovered JAK/STAT inhibitors?
    Sardana K; Gupta A; Gautam RK
    Pediatr Dermatol; 2018 Nov; 35(6):856-858. PubMed ID: 30318623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case reports: alopecia universalis: hair growth following initiation of simvastatin and ezetimibe therapy.
    Robins DN
    J Drugs Dermatol; 2007 Sep; 6(9):946-7. PubMed ID: 17941369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.